Of the 9 new shares listed in the last week of 2021, 4 broke on the first day.
Among them, namo bio performed the worst. After its listing on December 28, its share price once fell by nearly 20%, reaching a low of 69.01 yuan, and finally fell sharply by 18.02% on the first day. Among the investors, namo bio had a maximum loss of 7805 yuan. In the first week of 2022, 8 new shares will start online subscription. Among them, the largest shareholder of Aojie technology, a communication chip enterprise subscribed online on January 4, is Ali network, holding 17.15% of the company’s equity.
four new shares broke last week
Of the 9 new shares listed last week (December 27-31, 2021), 4 broke on the first day. In terms of decline, namo bio performed the worst. After its listing on December 28, its share price once fell by nearly 20%, reaching a low of 69.01 yuan, and finally fell sharply by 18.02% on the first day. Among the investors, namo bio had a maximum loss of 7805 yuan.
Statistics show that the initial price of Nanmo biology is 84.62 yuan. The company is mainly engaged in genetically modified animal models and related technical services. Nanmo biology expects the company to achieve an operating revenue range of 260-290 million yuan in 2021, with a year-on-year increase of 32.52% – 47.82%; The net profit was 50-65 million yuan, a year-on-year increase of 12.22% – 45.88%.
The other three new shares, oney electronics, Pingao shares and Chunli medical, closed down 12.07%, 11.51% and 3.99% respectively on the first day of listing.
Based on the closing price of the first day, the highest single sign profit, UNIWIN, made a single day profit of 9490 yuan. Youningwei is a large agent of life science reagents in China. The company has accumulated a wide range of high-quality customer groups, such as Qingbei Fujiao, Chinese Academy of Sciences, Wuxi Apptec Co.Ltd(603259) , Zhongshan Hospital Affiliated to Fudan University, etc; What needs to be vigilant is that the company currently relies on third-party brands and basically has no independent production. Nanmo biology, the company with the highest loss this week, is the leader in the field of model animals in China backed by the Chinese Academy of Sciences and the first in China in the field of customized models and model breeding and feeding.
So far, 22 new shares (new shares in Shanghai, Shenzhen and North China) were issued on the first day of 2021, of which Liaoning Chengda Biotechnology Co.Ltd(688739) closed down 27.27% on the first day, which was the new share with the largest decline on the first day of last year. In addition, last year, the closing price of 11 new shares fell by more than 10% on the first day of listing, and the myth of new invincibility has been broken.
Some market participants pointed out that since last year, the purchase of new shares has been abandoned continuously, and the breaking of new shares has also occurred continuously. With the promotion of the comprehensive registration system, new shares are no longer scarce, and the myth of stable profit of new shares has also been broken. In the future, investors should analyze more fundamentals and make innovations carefully.
the first listed bank this year
According to the current arrangement, if there is no change, there will be 8 new shares available for subscription in the first week of 2022 (January 4-7), including 2 on the science and innovation board, 4 on the gem, 1 on the Shenzhen main board and 1 on the Beijing stock exchange.
Among the new shares this week, Aojie technology, Maiwei biology, Xinghui environmental materials and Bank of Lanzhou all raised more than 2 billion yuan. Among them, Aojie technology raised 6.8 billion yuan and the issue price reached 164.45 yuan.
Aojie technology is a scarce wireless communication platform chip enterprise in China. Founded in 2015, the company is a platform chip enterprise providing wireless communication and super large-scale chips. In 2020, the company’s chip product revenue accounted for 81.9%, and the revenue of cellular baseband chips accounted for 89.9%. Benefiting from the company’s new product launch and customer scale expansion, the operating revenue increased rapidly from RMB 115 million in 2018 to RMB 1.080 billion in 2020. However, due to large R & D investment, it has not been profitable by 2020.
At present, Aojie technology, Maiwei biology, Xinghui environmental materials, Bank of Lanzhou and Hujiang materials have announced the issuance price, of which the issuance price of Aojie technology is 164.45 yuan. After deducting the issuance expenses, the IPO fund-raising will invest in the new communication chip design project, intelligent IPC chip design project, the integration of various wireless protocols and the overall solution and platform project of high-precision navigation and positioning in multiple fields.
It is noteworthy that the online subscription of Bank of Lanzhou on Wednesday (January 5) is the first listed bank this year.
Bank of Lanzhou issued 570 million new shares in this IPO at an issue price of RMB 3.57. The upper limit of online top grid subscription is 170500 shares, and the market value of top grid subscription is RMB 1.705 million. According to previous data, there is a certain positive correlation between the upper limit of online top grid subscription and the winning rate. The higher the upper limit of online top grid subscription, the higher the signing rate.
The prospectus shows that bank of Lanzhou was established in 1997. After years of development, it has become a regional urban commercial bank with a certain scale, stable operation and standardized governance. Lanzhou bank provides customers with corporate and personal banking products and services, and engages in capital business. It has successful experience and relative competitive advantages in the field of small and medium-sized enterprise customers, community finance and personalized financial services. As of June 30, 2021, Bank of Lanzhou has 1 head office business department, 15 branches, 165 sub branches, 1 holding financial leasing company and a total of 182 institutions.
(brokerage China)
